Browsing Over 32 Presentations

Sort By
Preclinical evidence of efficacy (ID 5) Educational session

Preclinical evidence of activity of palbociclib (ID 12)

Lecture Time
16:40 - 17:00
Speakers
  • Angel Guerrero (Valencia, ES)
Session Name
Preclinical evidence of efficacy (ID 5)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
23.03.2018
Time
16:40 - 18:10
Preclinical evidence of efficacy (ID 5) Educational session

Preclinical evidence of activity of ribociclib (ID 13)

Lecture Time
17:00 - 17:20
Speakers
  • Gustavo Baldassarre (Aviano, IT)
Session Name
Preclinical evidence of efficacy (ID 5)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
23.03.2018
Time
16:40 - 18:10
Preclinical evidence of efficacy (ID 5) Educational session

Preclinical evidence of activity of abemaciclib (ID 14)

Lecture Time
17:20 - 17:40
Speakers
  • Maria Lallena (Alcobendas, ES)
Session Name
Preclinical evidence of efficacy (ID 5)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
23.03.2018
Time
16:40 - 18:10
Preclinical evidence of efficacy (ID 5) Educational session

Comparison of preclinical data across CDK 4-6 (ID 15)

Lecture Time
17:40 - 18:00
Speakers
  • Romano Danesi (Pisa, IT)
Session Name
Preclinical evidence of efficacy (ID 5)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
23.03.2018
Time
16:40 - 18:10
Preclinical evidence of efficacy (ID 5) Educational session

Q&A (ID 16)

Lecture Time
18:00 - 18:10
Session Name
Preclinical evidence of efficacy (ID 5)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
23.03.2018
Time
16:40 - 18:10
Role of CDK 4-6 inhibitors across solid tumors (ID 9) Panel Discussion

Panel Discussion (ID 35)

Lecture Time
15:20 - 16:05
Speakers
  • Alberto Bardelli (Candiolo, IT)
  • Josep Tabernero (Barcelona, ES)
Session Name
Role of CDK 4-6 inhibitors across solid tumors (ID 9)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
15:20 - 16:05
The concept of CDK inhibition according to the targeted CDK subtype (ID 4) Educational session

Mechanism of resistance to CDKs inhibitors (ID 33)

Lecture Time
15:50 - 16:10
Speakers
  • Giulio Draetta (Houston, US)
Session Name
The concept of CDK inhibition according to the targeted CDK subtype (ID 4)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
23.03.2018
Time
14:30 - 16:20
The concept of CDK inhibition according to the targeted CDK subtype (ID 4) Educational session

CDK2 as the bypass kinase for CDK4/6 inhibition (ID 7)

Lecture Time
14:50 - 15:10
Speakers
  • Nicholas Turner (London, GB)
Session Name
The concept of CDK inhibition according to the targeted CDK subtype (ID 4)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
23.03.2018
Time
14:30 - 16:20
The concept of CDK inhibition according to the targeted CDK subtype (ID 4) Educational session

The role of CDK4, CDK2 and CDK1 in KRas driven lung tumors: The good, the bad and the ugly (ID 8)

Lecture Time
15:10 - 15:30
Speakers
  • Mariano Barbacid (Madrid, ES)
Session Name
The concept of CDK inhibition according to the targeted CDK subtype (ID 4)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
23.03.2018
Time
14:30 - 16:20
The concept of CDK inhibition according to the targeted CDK subtype (ID 4) Educational session

CDK 4-6 inhibition (ID 9)

Lecture Time
14:30 - 14:50
Speakers
  • Monica Arnedos (Villejuif, FR)
Session Name
The concept of CDK inhibition according to the targeted CDK subtype (ID 4)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
23.03.2018
Time
14:30 - 16:20
The concept of CDK inhibition according to the targeted CDK subtype (ID 4) Educational session

DNA damage and checkpoint kinases (ID 10)

Lecture Time
15:30 - 15:50
Speakers
  • Fabrizio D'Adda di Fagagna (Milan, IT)
Session Name
The concept of CDK inhibition according to the targeted CDK subtype (ID 4)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
23.03.2018
Time
14:30 - 16:20
The concept of CDK inhibition according to the targeted CDK subtype (ID 4) Educational session

Q&A (ID 11)

Lecture Time
16:10 - 16:20
Session Name
The concept of CDK inhibition according to the targeted CDK subtype (ID 4)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
23.03.2018
Time
14:30 - 16:20